ArticleFrontiers in oncology2022

Differential prognostic impact of stratified additional chromosome abnormalities on disease progression among Malaysian chronic myeloid leukemia patients undergoing treatment with imatinib mesylate.

Ismail Siti Mariam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.